KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Debt to Equity (2020 - 2025)

Historic Debt to Equity for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $0.03.

  • Fulgent Genetics' Debt to Equity rose 444.01% to $0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.03, marking a year-over-year increase of 444.01%. This contributed to the annual value of $0.03 for FY2024, which is 1759.4% up from last year.
  • Latest data reveals that Fulgent Genetics reported Debt to Equity of $0.03 as of Q3 2025, which was up 444.01% from $0.03 recorded in Q2 2025.
  • Fulgent Genetics' Debt to Equity's 5-year high stood at $0.06 during Q2 2021, with a 5-year trough of $0.01 in Q2 2023.
  • Its 5-year average for Debt to Equity is $0.02, with a median of $0.02 in 2023.
  • Its Debt to Equity has fluctuated over the past 5 years, first crashed by 6028.92% in 2022, then surged by 12326.61% in 2024.
  • Fulgent Genetics' Debt to Equity (Quarter) stood at $0.02 in 2021, then dropped by 14.84% to $0.01 in 2022, then soared by 56.15% to $0.02 in 2023, then increased by 17.59% to $0.03 in 2024, then rose by 1.98% to $0.03 in 2025.
  • Its Debt to Equity was $0.03 in Q3 2025, compared to $0.03 in Q2 2025 and $0.03 in Q1 2025.